[Metabolic syndrome: Towards cell therapy by using CRISPR/Cas9-engineered human adipocytes]
Med Sci (Paris)
.
2021 Jun-Jul;37(6-7):585-587.
doi: 10.1051/medsci/2021071.
Epub 2021 Jun 28.
[Article in French]
Authors
Morgane Baron
1
,
Amélie Bonnefond
1
Affiliation
1
Inserm UMR1283, CNRS UMR8199, European genomic institute for diabetes (EGID), Institut Pasteur de Lille, 1 place de Verdun, 59000 Lille, France. - Université de Lille, CHU de Lille, 59000 Lille, France.
PMID:
34180815
DOI:
10.1051/medsci/2021071
No abstract available
MeSH terms
Adipocytes
CRISPR-Cas Systems*
Cell- and Tissue-Based Therapy
Gene Editing
Humans
Metabolic Syndrome* / genetics
Metabolic Syndrome* / therapy